Pharma industry emerges as nation's biggest lobbyist

The pharmaceutical industry has run up an $800 million tab for lobbying Congress and backing political candidates over the past seven years, making it the "goliath" of American lobbying groups. The tab breaks down to $675 million in lobbying, $87 million in campaign donations to federal candidates and political parties and $10 million for advocacy groups, according to the Center for Public Integrity.

"During the period studied, Congress and executive branch agencies weakened federal oversight of the industry, strengthened patent protections, extended patents, granted tax credits and protected the industry's interests at home and abroad," according to the CPI.  PhRMA called the report "biased and one-sided."

- read this report from The Star-Ledger for more

Suggested Articles

The FDA rejected the new drug application for golodirsen, the follow-up to Exondys 51, Sarepta’s first treatment for Duchenne muscular dystrophy.

Levi Garraway is set to take up one of the biggest hot seats in biopharma when he becomes the next chief medical officer at Roche.

Vanda Pharmaceuticals received a Complete Response Letter from the FDA taking issue with a small study testing Hetlioz in jet lag disorder.